Plasma and urine free and acyl carnitine were measured in 19 children with nephropathic cystinosis and renal Fanconi syndrome. Each patient exhibited a deficiency of plasma free carnitine (mean 11.7 +/- 4.0 [SD] nmol/ml) compared with normal control values (42.0 +/- 9.0 nmol/ml) (P less than 0.001). Mean plasma acyl carnitine in the cystinotic subjects was normal. Four subjects with Fanconi syndrome but not cystinosis displayed the same abnormal pattern of plasma carnitine levels; controls with acidosis or a lysosomal storage disorder (Fabry disease), but not Fanconi syndrome, had entirely normal plasma carnitine levels. Two postrenal transplant subjects with cystinosis but without Fanconi syndrome also had normal plasma carnitine levels. Absolute amounts of urinary free carnitine were elevated in cystinotic individuals with Fanconi syndrome. In all 21 subjects with several different etiologies for the Fanconi syndrome, the mean fractional excretion of free carnitine (33%) as well as acyl carnitine (26%) greatly exceeded normal values (3 and 5%, respectively). Total free carnitine excretion in Fanconi syndrome patients correlated with total amino acid excretion (r = 0.76). Two cystinotic patients fasted for 24 h and one idiopathic Fanconi syndrome patient fasted for 5 h showed normal increases in plasma beta-hydroxybutyrate and acetoacetate, which suggested that hepatic fatty acid oxidation was intact despite very low plasma free carnitine levels. Muscle biopsies from two cystinotic subjects with Fanconi syndrome and plasma carnitine deficiency had 8.5 and 13.1 nmol free carnitine per milligram of noncollagen protein, respectively (normal controls, 22.3 and 17.1); total carnitines were 11.8 and 13.3 nmol/mg noncollagen protein (controls 33.5, 20.0). One biopsy revealed a mild increase in lipid droplets. The other showed mild myopathic features with variation in muscle fiber size, small vacuoles, and an increase in lipid droplets. In renal Fanconi syndrome, failure to reabsorb free and acyl carnitine results in a secondary plasma and muscle free carnitine deficiency.
I Bernardini, W B Rizzo, M Dalakas, J Bernar, W A Gahl
Title and authors | Publication | Year |
---|---|---|
Novel mechanism for tubular injury in nephropathic cystinosis
Sur S, Kerwin M, Pineda S, Sansanwal P, Sigdel TK, Sirota M, Sarwal MM |
eLife | 2025 |
Assessment of carnitine excretion and its ratio to plasma free carnitine as a biomarker for primary carnitine deficiency in newborns.
Crefcoeur LL, Heiner-Fokkema MR, Maase RE, Visser G, de Sain-van der Velden MGM |
JIMD reports | 2022 |
Clinical and neurophysiological characterization of early neuromuscular involvement in children and adolescents with nephropathic cystinosis
N Elkhateeb, R Selim, NA Soliman, FM Atia, II Abouelwoun, MA Elmonem, R Helmy |
Pediatric Nephrology | 2021 |
Challenges in Analysis of Hydrophilic Metabolites Using Chromatography Coupled with Mass Spectrometry
Q Hu, H Tang, Y Wang |
2020 | |
Kinetics of Serum Carnitine Fractions in Patients With Chronic Kidney Disease Not on Dialysis
J Yano, S Ito, G Kodama, Y Nakayama, Y Kaida, Y Yokota, Y Kinoshita, K Tashiro, K Fukami |
The Kurume Medical Journal | 2020 |
Carnitine promotes recovery from oxidative stress and extends lifespan in C. elegans
D Liu, X Zeng, L Li, ZL Ou |
Aging | 2020 |
Comprehensive Analysis of Acylcarnitine Species in db/db Mouse Using a Novel Method of High-Resolution Parallel Reaction Monitoring Reveals Widespread Metabolic Dysfunction Induced by Diabetes
L Xiang, J Wei, XY Tian, B Wang, W Chan, S Li, Z Tang, H Zhang, WS Cheang, Q Zhao, H Zhao, Z Yang, Y Hong, Y Huang, Z Cai |
Analytical Chemistry | 2017 |
Carnitine insufficiency in children with inborn errors of metabolism: prevalence and treatment efficacy
I Mamedov, I Zolkina, E Nikolaeva, P Glagovsky, V Sukhorukov |
Journal of Pediatric Endocrinology and Metabolism | 2015 |
JIMD Reports
M Besouw, E Cornelissen, D Cassiman, L Kluijtmans, L Heuvel, E Levtchenko |
JIMD reports | 2014 |
Carnitine Metabolism and Human Nutrition
S Wicks, R Noland, R Mynatt |
Carnitine Metabolism and Human Nutrition | 2014 |
Cystinosis: the evolution of a treatable disease
G Nesterova, WA Gahl |
Pediatric Nephrology | 2012 |
Carnitine and Acylcarnitines: Pharmacokinetic, Pharmacological and Clinical Aspects
SE Reuter, AM Evans |
Clinical Pharmacokinetics | 2012 |
Fanconi Syndrome Associated with Valporic Acid: A Case Report
R Shiari, L Bagherzade, MR Alaei |
Iranian Red Crescent Medical Journal | 2011 |
Role of carnitine in cancer chemotherapy-induced multiple organ toxicity
MM Sayed-Ahmed |
Saudi Pharmaceutical Journal | 2010 |
Increased Insulin Sensitivity in Mice Lacking Collectrin, a Downstream Target of HNF-1α
SM Malakauskas, WM Kourany, XY Zhang, D Lu, RD Stevens, TR Koves, HE Hohmeier, DM Muoio, CB Newgard, TH Le |
Molecular Endocrinology | 2009 |
Carnitine deficiency and l-carnitine supplementation in lysinuric protein intolerance
LM Tanner, K Näntö-Salonen, MS Rashed, S Kotilainen, M Aalto, J Venetoklis, H Niinikoski, K Huoponen, O Simell |
Metabolism | 2008 |
Nephropathic cystinosis: late complications of a multisystemic disease
G Nesterova, W Gahl |
Pediatric Nephrology | 2008 |
L-carnitine supplementation in the dialysis population: Are Australian patients missing out?
SE Reuter, RJ Faull, AM Evans |
Nephrology | 2007 |
Side Effects of Drugs Annual
T Vial, J Descotes, F Braun, M Behrend |
Side Effects of Drugs Annual | 2007 |
Disposition and Metabolite Kinetics of Oral L-carnitine in Humans
MA Bain, RW Milne, AM Evans |
The Journal of Clinical Pharmacology | 2006 |
Physician’s Guide to the Treatment and Follow-Up of Metabolic Diseases
N Blau, J Leonard, GF Hoffmann, JT Clarke |
2006 | |
Nutrition in Exercise & Sport
J Cooper, P Deuster |
Sports Nutrition | 2005 |
The use of levo-carnitine in children with renal disease: a review and a call for future studies
B Belay, N Esteban-Cruciani, CA Walsh, FJ Kaskel |
Pediatric Nephrology | 2005 |
Debate Forum: Levocarnitine Therapy Is Rational and Justified in Selected Dialysis Patients
BD Schreiber |
Blood Purification | 2005 |
Atlas of Metabolic Diseases Second edition
W Nyhan, B Barshop, P Ozand |
Atlas of Metabolic Diseases Second edition | 2005 |
Pharmacokinetics of L-Carnitine:
AM Evans, G Fornasini |
Clinical Pharmacokinetics | 2003 |
Infantile cystinosis presenting as chronic constipation
FK Assadi, RH Sandler, PW Wong, M Salem, L Simenauer |
American Journal of Kidney Diseases | 2002 |
Laboratory approach to mitochondrial diseases
D Parra, A González, C Mugueta, A Martínez, I Monreal |
Journal of Physiology and Biochemistry | 2001 |
Evaluation of Urinary Carnitine and Taurine Excretion in 5 Cystinuric Dogs with Carnitine and Taurine Deficiency
SL Sanderson, CA Osborne, JP Lulich, JW Bartges, ME Pierpont, PN Ogburn, LA Koehler, LL Swanson, KA Bird, LK Ulrich |
Journal of Veterinary Internal Medicine | 2001 |
Effect of gamma-butyrobetaine on fatty liver in juvenile visceral steatosis mice
Y Higashi, K Yokogawa, N Takeuchi, I Tamai, M Nomura, N Hashimoto, J I Hayakawa, K I Miyamoto, A Tsuji |
The Journal of pharmacy and pharmacology | 2001 |
Carnitine-Deficient Myopathy as a Presentation of Tyrosinemia Type I
A Nissenkom, SH Korman, O Vardi, A Levine, Z Katzir, A Ballin, T Lerman-Sagie |
Journal of child neurology | 2001 |
Metabolic myopathies: a clinical approach; part II
BT Darras, NR Friedman |
Pediatric Neurology | 2000 |
Lipid storage myopathy in a cocker spaniel
SR Platt, CL Chrisman, GD Shelton |
Journal of Small Animal Practice | 1999 |
GENETIC DISORDERS OF CARNITINE METABOLISM AND THEIR NUTRITIONAL MANAGEMENT1
J Kerner, C Hoppel |
Annual Review of Nutrition | 1998 |
Carnitine metabolism changes during the first year after a successful kidney transplantation
Z Zdrojewski, E Kisielnicka, E Król, J Fox, G Kuchta, B Rutkowski, W Łysiak-Szydłowska |
Transplantation Proceedings | 1997 |
Carnitine metabolism in patients with chronic liver disease: Carnitine metabolism in patients with chronic liver disease
S Krähenbühl, J Reichen |
Hepatology | 1997 |
Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS
WN Suki, SG Massry |
1997 | |
Carnitine metabolism in chronic liver disease
S Krähenbühl |
Life Sciences | 1996 |
L-Carnitine
JH Walter |
Archives of disease in childhood | 1996 |
Cystinosis
JG Thoene |
Journal of Inherited Metabolic Disease | 1995 |
Osteomalacia associated with adult Fanconi's syndrome: clinical and diagnostic features
BL Clarke, AG Wynne, DM Wilson, LA Fitzpatrick |
Clinical Endocrinology | 1995 |
Medullary nephrocalcinosis in nephropathic cystinosis
DS Theodoropoulos, TH Shawker, C Heinrichs, WA Gahl |
Pediatric Nephrology | 1995 |
Intraoperative hyperthermia in a paediatric patient with cystinosis
JP Purday, CJ Montgomery, D Blackstock |
Pediatric Anesthesia | 1995 |
Renal handling of carnitine in ill preterm and term neonates
S Zamora, N Benador, G Lacourt, E Girardin |
The Journal of Pediatrics | 1995 |
Distal vacuolar myopathy in nephropathic cystinosis
LR Charnas, CA Luciano, M Dalakas, RW Gilliatt, I Bernardini, K Ishak, VA Cwik, D Fraker, TA Brushart, WA Gahl |
Annals of Neurology | 1994 |
Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage
MC Dalakas, ME Leon-Monzon, I Bernardini, WA Gahl, CA Jay |
Annals of Neurology | 1994 |
Primary defect of juvenile visceral steatosis (jvs) mouse with systemic carnitine deficiency is probably in renal carnitine transport system
M Horiuchi, K Kobayashi, S Yamaguchi, N Shimizu, T Koizumi, H Nikaido, J Hayakawa, M Kuwajima, T Saheki |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 1994 |
Neurologic Emergencies in Infancy and Childhood
AM Chutorian, SG Pavlakis |
Neurologic Emergencies in Infancy and Childhood | 1993 |
Indian childhood cirrhosis in an American child
M Adamson, B Reiner, JL Olson, Z Goodman, L Plotnick, I Bernardini, WA Gahl |
Gastroenterology | 1992 |
Animal model of systemic carnitine deficiency: Analysis in C3H-H-2° strain of mouse associated with juvenile visceral steatosis
M Kuwajima, N Kono, M Horiuchi, Y Imamura, A Ono, Y Inui, S Kawata, T Koizumi, J Hayakawa, T Saheki, S Tarui |
Biochemical and Biophysical Research Communications | 1991 |
Clinical and Laboratory Findings in the Oculocerebrorenal Syndrome of Lowe, with Special Reference to Growth and Renal Function
LR Charnas, I Bernardini, D Rader, JM Hoeg, WA Gahl |
New England Journal of Medicine | 1991 |
Treatment of cystinosis with cysteamine from early infancy
VM Reznik, M Adamson, RD Adelman, JL Murphy, WA Gahl, KF Clark, JA Schneider |
The Journal of Pediatrics | 1991 |
The effect of carnitine supplementation on carnitine balance in patients with persistent post-operative infection
M Soop, E Forsberg, A Thörne, G Cederblad, J Wahren |
Clinical Nutrition | 1990 |
Update on nephropathic cystinosis
JA Schneider, B Katz, RB Melles |
Pediatric Nephrology | 1990 |
Carnitine deficiency
SC Winter, EM Zorn, WH Vance, RA Chalmers, MD Bain, TE Stacey, CD Sousa |
The Lancet | 1990 |
Carnitine Metabolism and Usage in Chronic Dialysis Patients
PS Kurtin |
Seminars in Dialysis | 1990 |
Analysis of acylcarnitines in normal human urine with the radioisotopic exchange-high performance liquid chromatography (HPLC) method
E Schmidt-Sommerfeld, D Penn, J Kerner, LL Bieber |
Clinica Chimica Acta | 1989 |
Urine glyceraldehyde excretion is elevated in the renal Fanconi syndrome
AJ Jonas, SN Lin, SB Conley, JA Schneider, JC Williams, RC Caprioli |
Kidney International | 1989 |
CARNITINE DEFICIENCY INDUCED BY PIVAMPICILLIN AND PIVMECILLINAM THERAPY
E Holme, CE Jacobson, I Nordin, J Greter, S Lindstedt, B Kristiansson, U Jodal |
The Lancet | 1989 |
Transsulfuration in an adult with hepatic methionine adenosyltransferase deficiency
WA Gahl, I Bernardini, JD Finkelstein, A Tangerman, JJ Martin, HJ Blom, KD Mullen, SH Mudd |
Journal of Clinical Investigation | 1988 |
Oral carnitine therapy in children with cystinosis and renal Fanconi syndrome
WA Gahl, I Bernardini, M Dalakas, WB Rizzo, GS Harper, JM Hoeg, O Hurko, J Bernar |
Journal of Clinical Investigation | 1988 |
Myopathy and Cystine Storage in Muscles in a Patient with Nephropathic Cystinosis
WA Gahl, MC Dalakas, L Charnas, KT Chen, GH Pezeshkpour, T Kuwabara, SL Davis, RW Chesney, J Fink, HT Hutchison |
New England Journal of Medicine | 1988 |
Myopathies Caused by Disorders of Lipid Metabolism
JE Carroll |
Neurologic Clinics | 1988 |
Lipoprotein lipase, hepatic lipase, and carnitine in premature infants
LM Rovamo, EA Nikkila, KO Raivio |
Archives of disease in childhood | 1988 |
Hepatic methionine adenosyltransferase deficiency in a 31-year-old man
WA Gahl, JD Finkelstein, KD Mullen, I Bernardini, JJ Martin, P Backlund, KG Ishak, JH Hoofnagle, SH Mudd |
The American Journal of Human Genetics | 1987 |
Removal of Corneal Crystals by Topical Cysteamine in Nephropathic Cystinosis
MI Kaiser-Kupfer, L Fujikawa, T Kuwabara, S Jain, WA Gahl |
New England Journal of Medicine | 1987 |
Cysteamine Therapy for Children with Nephropathic Cystinosis
WA Gahl, GF Reed, JG Thoene, JD Schulman, WB Rizzo, AJ Jonas, DW Denman, JJ Schlesselman, BJ Corden, JA Schneider |
New England Journal of Medicine | 1987 |
Complications of nephropathic cystinosis after renal failure
WA Gahl, MI Kaiser-Kupfer |
Pediatric Nephrology | 1987 |
Carnitine: An overview of its role in preventive medicine
BS Kendler |
Preventive Medicine | 1986 |
Therapy of Renal Diseases and Related Disorders
WN Suki, SG Massry |
1984 |